Biote Corp. BTMD Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.43M-14.7% | $31.6M+68,589% | $32.46M+655% | $35.9M+218% | $21.61M+153% | ||
| $3.79M+3.0% | $3.67M+2.7% | $3.86M-2.3% | $3.72M+4.6% | $3.68M+14.8% | ||
| $8.55M-6.0% | $8.92M+2.1% | $8.61M-2.7% | $8.44M-4.5% | $9.1M+5.2% | ||
| $3.51M— | $4.22M— | -$3.85M— | -$1.61M— | —— | ||
| $828K0.0% | $833K+1.7% | $832K+3.0% | $827K+2.5% | $828K+3.4% | ||
| $515K-75.5% | $1.72M+15.5% | $2.17M+128% | $1.61M— | $2.1M— | ||
| —— | —— | —— | —— | —— | ||
| $6.89M+250% | $6.24M+268% | $997K-75.4% | -$5.52M-154% | -$4.59M-161% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $2.18M— | $3.15M— | ||
| -$716K— | -$400K— | —— | —— | —— | ||
| -$540K+33.7% | -$523K+31.4% | -$482K+34.4% | -$847K-58.0% | -$815K-81.1% | ||
| -$2.01M+28.6% | -$1.69M+41.2% | -$2.35M— | $323K— | -$2.81M— | ||
| $32.63M-26.4% | $35.19M-22.2% | $39.99M+0.4% | $41.48M+69.7% | $44.34M+109% | ||
| $3.75M-49.1% | $5.02M-22.0% | $5.61M— | $6.66M— | $7.36M— | ||
| -$6.18M+27.0% | -$6.86M+63.5% | -$5.81M— | -$7.1M— | -$8.47M— | ||
| $1.44M-73.1% | $1.73M-63.6% | $1.68M-70.9% | $2.12M-66.4% | $5.36M-5.8% | ||
| $3.59M— | $3.37M— | —— | —— | —— | ||
| $11.25M— | $5M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| -$62.84M+13.8% | -$43.56M+42.8% | -$44.36M+35.4% | -$41.19M+40.7% | -$72.93M-369% | ||
| $12K+150% | $6K+127% | -$1K+95.2% | -$9K+48.6% | -$24K-47.7% | ||
| —— | —— | —— | —— | —— | ||
| $7.62M-18.3% | $7.88M-17.4% | $8.26M-15.6% | $9.59M+8.1% | $9.32M-1.6% | ||
| $3.15M+21.3% | $3.03M+16.7% | $2.81M-28.3% | $2.89M— | $2.59M— | ||
| $828K0.0% | $833K+1.7% | $832K+3.0% | $827K+2.5% | $828K+3.4% | ||
| —— | —— | —— | —— | —— | ||
| -$716K— | -$400K— | —— | —— | —— | ||
| -$540K+33.7% | -$523K+31.4% | -$482K+34.4% | -$847K-58.0% | -$815K-81.1% | ||
| -$2.01M+28.6% | -$1.69M+41.2% | -$2.35M— | $323K— | -$2.81M— | ||
| —— | —— | —— | —— | —— | ||
| $632K— | $2.19M— | —— | —— | —— | ||
| —— | $3.18M— | $3.8M— | $4.11M— | —— | ||
| $555K-36.1% | $545K-33.1% | $535K-29.7% | $903K+66.6% | $868K+70.2% | ||
| $515K-75.5% | $1.72M+15.5% | $2.17M+128% | $1.61M— | $2.1M— | ||
| $2.44M— | $1.85M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $6.25M0.0% | $6.25M0.0% | $6.25M0.0% | $6.25M0.0% | $6.25M0.0% | ||
| $12K+150% | $6K+127% | -$1K+95.2% | -$9K+48.6% | -$24K-47.7% | ||
| -$540K+33.7% | -$523K+31.4% | -$482K+34.4% | -$847K-58.0% | -$815K-81.1% | ||
| $28.88M-21.9% | $30.18M-22.2% | $34.39M-2.4% | $34.82M+64.1% | $36.98M+79.9% | ||
| $28.88M-21.9% | $30.18M-22.2% | $34.39M-2.4% | $34.82M+64.1% | $36.98M+79.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Biote Corp. generate?
- Biote Corp. (BTMD) generated $32.6M in operating cash flow over the trailing twelve months.
- What is Biote Corp.'s free cash flow?
- After $3.7M of capital expenditures, Biote Corp.'s free cash flow was $28.9M over the trailing twelve months, down 21.9% year over year.
- Where does Biote Corp.'s cash flow data come from?
- Every line is extracted from Biote Corp.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
